Skip to content
Brazil
-
Gilead, Merck present pivotal Phase 3 Islend data for first once-weekly oral HIV regimen
Researchers presented the findings at the 26th International AIDS Conference in Rio de Janeiro, Brazil.
-
Sanofi disinvests Brazilian generics unit Medley to EMS in USD500M deal
Rather than consolidating operations through plant closures, EMS intends to retain Medley’s existing facilities and invest in future expansion.